Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

GLPG

Galapagos (GLPG)

Galapagos
Date:
Sort by:
 Showing the most relevant articles for your search:EU:GLPG
DateTimeSourceHeadlineSymbolCompany
09/29/20161:40AMGlobeNewswire Inc.MorphoSys and Galapagos Start First-In-Patient Dosing of IL-17C Antibody MOR106 in Atopic DermatitisEU:GLPGGalapagos
09/27/20164:04PMGlobeNewswire Inc.Successful completion of regulatory consultations to progress filgotinib to Phase 3 in inflammatory bowel diseaseEU:GLPGGalapagos
09/25/20168:20PMGlobeNewswire Inc.Endoscopic improvements with filgotinib are consistent with clinical remission rates in patients with Crohn's diseaseEU:GLPGGalapagos
09/19/20164:10PMGlobeNewswire Inc.Galapagos increases share capital through warrant exercisesEU:GLPGGalapagos
08/23/20164:47AMCercle FinanceGalapagos: lance un programme clinique de phase III.EU:GLPGGalapagos
08/22/20164:09PMGlobeNewswire Inc.FINCH filgotinib Phase 3 program initiated in rheumatoid arthritisEU:GLPGGalapagos
07/29/20164:08PMGlobeNewswire Inc.Galapagos receives transparency notification from FederatedEU:GLPGGalapagos
07/28/20164:20PMGlobeNewswire Inc.Focus on filgotinib and cystic fibrosisEU:GLPGGalapagos
06/23/20161:33AMGlobeNewswire Inc.Invitation to the Special and Extraordinary Shareholders' Meetings of 26 July 2016 - Nomination of Mary Kerr for Galapagos' B...EU:GLPGGalapagos
06/15/20161:36AMGlobeNewswire Inc.Galapagos' R&D Update 2016EU:GLPGGalapagos
06/09/20163:55AMCercle FinanceGalapagos: le groupe va intégrer l'AEX.EU:GLPGGalapagos
06/09/20161:34AMGlobeNewswire Inc.Galapagos selected for AEX IndexEU:GLPGGalapagos
06/01/20164:05PMGlobeNewswire Inc.Galapagos creates new warrant planEU:GLPGGalapagos
05/25/20164:04PMGlobeNewswire Inc.FITZROY Phase 2 study with filgotinib in Crohn's Disease presented as late breaker at DDW 2016EU:GLPGGalapagos
05/25/20167:42AMCercle FinanceGalapagos: en hausse après un feu vert pour une étude.EU:GLPGGalapagos
05/24/20164:09PMGlobeNewswire Inc.Successful completion of End-of-Phase 2 FDA and EMA consultations in rheumatoid arthritis (RA)EU:GLPGGalapagos
05/19/20164:25PMGlobeNewswire Inc.Galapagos increases share capital through warrant exercisesEU:GLPGGalapagos
05/17/20161:10AMGlobeNewswire Inc.Listing of existing shares on Euronext Brussels & AmsterdamEU:GLPGGalapagos
05/09/20164:09PMGlobeNewswire Inc.Galapagos starts Phase 1 study with potentiator GLPG2451 for CFEU:GLPGGalapagos
04/29/20161:04AMGlobeNewswire Inc.Galapagos and AbbVie expand their cystic fibrosis collaborationEU:GLPGGalapagos
04/28/20164:13PMGlobeNewswire Inc.Galapagos kick-starts 2016 with Q1 cash position of EU988 MEU:GLPGGalapagos
04/21/20164:03PMGlobeNewswire Inc.Galapagos reports additional data with filgotinib from the Phase 2 FITZROY studyEU:GLPGGalapagos
04/07/201610:13AMGlobeNewswire Inc.Galapagos and MorphoSys initiate Phase 1 study in joint antibody program MOR106EU:GLPGGalapagos
04/06/20164:09PMGlobeNewswire Inc.Galapagos initiates a Phase 2a study with GLPG1690 in idiopathic pulmonary fibrosis patientsEU:GLPGGalapagos
04/03/20164:29PMGlobeNewswire Inc.Galapagos increases share capital through warrant exercisesEU:GLPGGalapagos
03/25/20165:06PMGlobeNewswire Inc.Publication of the annual report and invitation to the Annual and Extraordinary Shareholders' MeetingsEU:GLPGGalapagos
03/18/20162:33AMGlobeNewswire Inc.Results from 10-week analysis of Phase 2 study with filgotinib in Crohn's Disease presented at ECCOEU:GLPGGalapagos
03/16/20165:26PMGlobeNewswire Inc.Galapagos doses first CF patient with G551D mutation in SAPHIRA 1 studyEU:GLPGGalapagos
03/07/20161:34AMGlobeNewswire Inc.Galapagos selected for BEL 20 IndexEU:GLPGGalapagos
03/03/20164:18PMGlobeNewswire Inc.Galapagos reports largest cash balance everEU:GLPGGalapagos
 Showing the most relevant articles for your search:EU:GLPG

Your Recent History

Delayed Upgrade Clock